Novelion Therapeutics is based in Vancouver, Canada. It has raised $22M in total funding. Backed by Deerfield, Armistice Capital, Broadfin Capital.
Novelion Therapeutics funding overview
Novelion Therapeutics is based in Vancouver, Canada. Novelion Therapeutics has raised $22M in total disclosed funding. That places its disclosed total in the $1M–$25M range. The round record for Novelion Therapeutics runs through 2016; nothing later has been disclosed. Investors on record include Deerfield, Armistice Capital, Broadfin Capital, Healthcare Value Capital, JW Asset Management, K2 & Associates Investment Management and 3 others. 9 distinct backers are named across the disclosed rounds.
Novelion Therapeutics at a glance
Total raised
$22M
Latest round date
November 2016
Headquarters
Vancouver, Canada
Notable investors
Deerfield, Armistice Capital, Broadfin Capital, Healthcare Value Capital, JW Asset Management, K2 & Associates Investment Management, Sarissa Capital, Jason Aryeh
Frequently asked about Novelion Therapeutics funding
How much has Novelion Therapeutics raised?
Novelion Therapeutics has raised $22M in total disclosed funding across the rounds on record.
Who has invested in Novelion Therapeutics?
Deerfield, Armistice Capital, Broadfin Capital, Healthcare Value Capital, JW Asset Management, K2 & Associates Investment Management are named among the investors backing Novelion Therapeutics.
What was the latest Novelion Therapeutics funding round?
No round stage has been disclosed for Novelion Therapeutics.
Where is Novelion Therapeutics based?
Novelion Therapeutics is based in Vancouver, Canada.
When did Novelion Therapeutics last raise?
The last disclosed Novelion Therapeutics round closed in November 2016.
Novelion Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Vancouver below to benchmark round size and investor mix.
